TMC 2020 A & B Exam Questions with
Correct Answers Brand New 2026 Top
Rated A+
Which of the following indicates a physical conditioning program has
been effective for a patient with COPD after 2 months of therapy?
An increase in 60 meters distance during the 6-minute walk
A 56-year-old male requires continuous mechanical ventilation
following cardiac arrest. His heart rate is 110/min and blood pressure
is 96/50 mm Hg. A pulmonary artery catheter has been inserted.
Patient data are:
Body surface area 2 m2
Cardiac output 3.6 L/min
PAP 30 mm Hg
PCWP 12 mm Hg
A respiratory therapist should recommend administering
A. a beta blocker.
B. a pulmonary vasodilator.
C. a diuretic.
D. an inotropic agent.
D. an inotropic agent.
,The data suggests a low cardiac index and cardiogenic shock. An
inotropic agent should be used to increase myocardial contractility,
which in turn, should increase blood pressure.
These flow-volume loops show the results of FVC maneuvers by a
patient before and after an albuterol treatment:
Which of the following should a respiratory therapist recommend
NEXT?
A. bronchoscopy for airway obstruction
B. noninvasive positive-pressure ventilation
C. inhaled bronchodilator therapy
D. supplemental oxygen therapy
C. inhaled bronchodilator therapy
The flow-volume loop obtained after bronchodilator administration
demonstrates a significant improvement in expiratory flow.
A 175-cm (5-ft 9-in) tall, 65-kg (143-lb) male with COPD and
pneumonia is receiving VC, SIMV with the following settings:
FIO2: 0.28
Mandatory rate: 8
Total rate: 16
VT: 500 mL
Vital signs have been stable for 48 hours and the following ABG
analysis results are available:
pH: 7.35
,PCO2: 52 mm Hg
PO2: 82 mm Hg
HCO3: 29 mEq/L
BE: +2 mEq/L
SO2 (calc): 96%
Which of the following should a respiratory therapist recommend?
A. Change to PC ventilation.
B. Titrate PS to achieve VT of 500 mL.
C. Extubate to an FIO2 of 0.40 with an aerosol mask.
D. Initiate a spontaneous breathing trial.
B. Titrate PS to achieve VT of 500 mL.
With the information provided, this patient qualifies for a spontaneous
breathing trial.
A patient with a PBW of 55 kg (121 lb) is receiving VC, A/C ventilation.
Ventilator settings and blood gas analysis results are:
FIO2: 0.70
Mandatory rate: 14
VT: 350 mL
PEEP: 5 cm H2O
pH: 7.35
PaCO2: 35 mm Hg
PaO2: 40 mm Hg
HCO3: 19 mEq/L
, BE: -6 mEq/L
SO2 (calc): 74%
A respiratory therapist should recommend the following:
A. changing to SIMV mode.
B. increasing to 10 cm H2O PEEP.
C. changing to 5 cm H2O CPAP.
D. increasing to 400 mL VT
B. increasing to 10 cm H2O PEEP.
The increase in PEEP will increase FRC, decrease the intrapulmonary
shunt, and address the hypoxemia.
When instructing a patient on the administration of
umeclidinium/vilanterol (Anoro Ellipta), which of the following is most
important to emphasize?
A. Gargle immediately after use.
B. Inhale slowly with a breath hold.
C. Breathe in fast and deep.
D. Shake medication vigorously before use.
C. Breathe in fast and deep.
Breathing in fast and deep is the proper method of administration for
umeclidinium/vilanterol (Anoro Ellipta).
Following placement of a tracheostomy tube for long-term mechanical
ventilation, which of the following patient positions best prevents
Correct Answers Brand New 2026 Top
Rated A+
Which of the following indicates a physical conditioning program has
been effective for a patient with COPD after 2 months of therapy?
An increase in 60 meters distance during the 6-minute walk
A 56-year-old male requires continuous mechanical ventilation
following cardiac arrest. His heart rate is 110/min and blood pressure
is 96/50 mm Hg. A pulmonary artery catheter has been inserted.
Patient data are:
Body surface area 2 m2
Cardiac output 3.6 L/min
PAP 30 mm Hg
PCWP 12 mm Hg
A respiratory therapist should recommend administering
A. a beta blocker.
B. a pulmonary vasodilator.
C. a diuretic.
D. an inotropic agent.
D. an inotropic agent.
,The data suggests a low cardiac index and cardiogenic shock. An
inotropic agent should be used to increase myocardial contractility,
which in turn, should increase blood pressure.
These flow-volume loops show the results of FVC maneuvers by a
patient before and after an albuterol treatment:
Which of the following should a respiratory therapist recommend
NEXT?
A. bronchoscopy for airway obstruction
B. noninvasive positive-pressure ventilation
C. inhaled bronchodilator therapy
D. supplemental oxygen therapy
C. inhaled bronchodilator therapy
The flow-volume loop obtained after bronchodilator administration
demonstrates a significant improvement in expiratory flow.
A 175-cm (5-ft 9-in) tall, 65-kg (143-lb) male with COPD and
pneumonia is receiving VC, SIMV with the following settings:
FIO2: 0.28
Mandatory rate: 8
Total rate: 16
VT: 500 mL
Vital signs have been stable for 48 hours and the following ABG
analysis results are available:
pH: 7.35
,PCO2: 52 mm Hg
PO2: 82 mm Hg
HCO3: 29 mEq/L
BE: +2 mEq/L
SO2 (calc): 96%
Which of the following should a respiratory therapist recommend?
A. Change to PC ventilation.
B. Titrate PS to achieve VT of 500 mL.
C. Extubate to an FIO2 of 0.40 with an aerosol mask.
D. Initiate a spontaneous breathing trial.
B. Titrate PS to achieve VT of 500 mL.
With the information provided, this patient qualifies for a spontaneous
breathing trial.
A patient with a PBW of 55 kg (121 lb) is receiving VC, A/C ventilation.
Ventilator settings and blood gas analysis results are:
FIO2: 0.70
Mandatory rate: 14
VT: 350 mL
PEEP: 5 cm H2O
pH: 7.35
PaCO2: 35 mm Hg
PaO2: 40 mm Hg
HCO3: 19 mEq/L
, BE: -6 mEq/L
SO2 (calc): 74%
A respiratory therapist should recommend the following:
A. changing to SIMV mode.
B. increasing to 10 cm H2O PEEP.
C. changing to 5 cm H2O CPAP.
D. increasing to 400 mL VT
B. increasing to 10 cm H2O PEEP.
The increase in PEEP will increase FRC, decrease the intrapulmonary
shunt, and address the hypoxemia.
When instructing a patient on the administration of
umeclidinium/vilanterol (Anoro Ellipta), which of the following is most
important to emphasize?
A. Gargle immediately after use.
B. Inhale slowly with a breath hold.
C. Breathe in fast and deep.
D. Shake medication vigorously before use.
C. Breathe in fast and deep.
Breathing in fast and deep is the proper method of administration for
umeclidinium/vilanterol (Anoro Ellipta).
Following placement of a tracheostomy tube for long-term mechanical
ventilation, which of the following patient positions best prevents
